Clinical and pharmacological group: & nbsp

Antimicrobial, antiparasitic and anthelmintic agents

Included in the formulation
  • Hexasprees
    aerosol locally 
  • АТХ:

    R.02.A.A   Antiseptics

    Pharmacodynamics:

    Antiseptic for topical application in ENT practice. It is active against staphylococci, streptococci and corynebacteria, has a local anesthetic and anti-inflammatory effect.

    When topical application is characterized by prolonged action.

    Pharmacokinetics:

    Pharmacokinetics studies were not conducted.

    Indications:

    Local treatment of infectious and inflammatory diseases of the oral cavity, pharynx and larynx caused by microorganisms sensitive to biklotimol, including: acute and chronic pharyngitis; pharyngolaringitis; tonsillitis; condition after tonsillectomy; glossitis.

    X.J00-J06.J02   Acute pharyngitis

    X.J00-J06.J03   Acute tonsillitis

    X.J00-J06.J04   Acute laryngitis and tracheitis

    X.J30-J39.J31   Chronic rhinitis, nasopharyngitis and pharyngitis

    X.J30-J39.J35.0   Chronic tonsillitis

    X.J30-J39.J37   Chronic laryngitis and laryngotracheitis

    XI.K00-K14.K05   Gingivitis and periodontal disease

    XI.K00-K14.K12   Stomatitis and related lesions

    Contraindications:

    Children under 6 years; hypersensitivity to the components of the drug.

    Carefully:

    Avoid contact with eyes.

    Pregnancy and lactation:

    Possible use of the drug during pregnancy and lactation (breastfeeding).

    Dosing and Administration:

    The drug is administered inhalation for 2 injections 3 times a day, regardless of food intake.

    During the inhalation, the bottle should be kept upright. Shake the bottle before use.

    Side effects:

    AAllergic reactions.

    Overdose:

    Cases of overdose are not fixed. Treatment is symptomatic.

    Interaction:

    It is necessary to avoid simultaneous use of other medications for topical application in the oral cavity.

    Special instructions:

    If the therapeutic effect is absent or weak within 5 days, the therapy should be reviewed.

    Instructions
    Up